Informations:
Erreur:
ID
12870
Description
Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00942318
Lien
https://clinicaltrials.gov/show/NCT00942318
Mots-clés
Versions (1)
- 04/01/2016 04/01/2016 -
Téléchargé le
4 janvier 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Type 2 Diabetes Mellitus NCT00942318
Eligibility Type 2 Diabetes Mellitus NCT00942318
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00942318
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
diabetes mellitus type 2
Item
type 2 diabetes mellitus
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
C0441730 (UMLS CUI [1,2])
ID.2
Item
age > 18 years
boolean
long acting insulin; rapid acting insulin
Item
patients treated for at least 6 months by multiple daily insulin injections associating long acting insulin (at least 1 long acting insulin analog injection-glargine or detemir- or at least 2 nph insulin injections) plus mealtimes rapid acting insulin injections (human or analogs) +/- oral hypoglycemic agents.
boolean
C0304870 (UMLS CUI [1])
C0356365 (UMLS CUI [2])
C0356365 (UMLS CUI [2])
hba1c
Item
7,5% ≤ hba1c ≤ 10%
boolean
C0019018 (UMLS CUI [1])
Blood Glucose Self-Monitoring
Item
patients able to perform self-monitoring blood glucose (smbg) measurement and insulin injections.
boolean
C0005803 (UMLS CUI [1])
Blood Glucose Self-Monitoring
Item
smbg > 3/day
boolean
C0005803 (UMLS CUI [1])
diabetic retinopathy
Item
diabetic retinopathy contraindicating glycemic control intensification
boolean
C0011884 (UMLS CUI [1])
Comorbidity Limited Compliance behavior
Item
situation or pathology not allowing therapeutic education program (blindness, deafness, low language fluency…)
boolean
C0009488 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
Comorbidity Limited Compliance behavior
Item
situation or pathology not allowing insulin therapy self-management and / or portable insulin pump use (rheumatologic pathology, low visual acuity, …)
boolean
C0009488 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
pathology
Item
recent (<3 month) serious pathology
boolean
C0030664 (UMLS CUI [1])
Poor glycemic control
Item
planned treatment or therapy able to induce long-term glycemic control worsening
boolean
C0342299 (UMLS CUI [1])
glucocorticoids; octreotide
Item
long lasting (> 2 month) planned treatment with glucocorticoids, octreotide, lanreotide or danazol
boolean
C0017710 (UMLS CUI [1])
C0028833 (UMLS CUI [2])
C0028833 (UMLS CUI [2])
pregnancy
Item
pregnancy wish or ongoing pregnancy
boolean
C0549206 (UMLS CUI [1])
haemoglobinopathy
Item
known haemoglobinopathy.
boolean
C0019045 (UMLS CUI [1])
creatinin clearance
Item
creatinin clearance <30ml/min (mdrd formula).
boolean
C0201976 (UMLS CUI [1])
organ transplant
Item
organ transplant.
boolean
C0029216 (UMLS CUI [1])